MS
Markus Sieger
Director

Markus Sieger insider trades: Cyclo Therapeutics (CYTH) stock purchases

Director, Cyclo Therapeutics Last trade Apr 20, 2023 48 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
10
Open-market trades
since 2009
4
Companies
last trade 2023

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Markus reports to the SEC

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Apr 20, 2023CYTH↑ Buy$43K
Mar 29, 2022CYTH↑ Buy$27K
Mar 29, 2021CYTH↑ Buy$81K
Jan 26, 2021CYTH↑ Buy$64K
Apr 24, 2020CTDH↑ Buy$50K
Aug 23, 2019CTDH↑ Buy$22K
Feb 19, 2014CTDH↑ Buy$175K
Aug 19, 2011CEDC↑ Buy$67K
Mar 7, 2011CEDC↑ Buy$25K
May 28, 2009CEDC↑ Buy$23K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Markus Sieger's insider trades

Markus Sieger is a director at Cyclo Therapeutics (CYTH). Since May 28, 2009, Markus has reported 10 open-market purchases worth $577K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (25 filings), other transactions (12 filings), option exercises (2 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CYTH insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.